Avanos Medical, Inc. (AVNS) Stock Analysis

AVNS

Market Closed

Avanos Medical, Inc.

NYSEHealthcare Medical - Devices

2.29K employees

CEO: David C. Pacitti

Founded: 2014

$24.99

+$0.00(+NaN%)

Market Cap

1.17B

Beta

1.57

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

AVNS Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for AVNS built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Strong Sell

Pass %

28.57%

Score

2/7

Fair Value Estimate

Cash flow analysis • Multiple methods

-$16.80

AI Price Target

Machine learning • Price prediction

$27.99

Market Sentiment

News & social media analysis

0.00

Value Investor Price

Classic value analysis

$6.46

Financial Health

Bankruptcy risk assessment

2.31

Quality Score

Financial strength rating

4.00

AI Investment Grade

Deep analysis of filings & news

58.00

Key Investment Highlights

Important factors affecting AVNS investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

58.33% Good

Conditions Met

21.00/36.00

Due Diligence Score

58.33%

Due Diligence Conditions

Investment analysis conditions and results


	Pass
	Fail
	Fail
	Pass
	Pass
	Pass

Showing 1 to 6 of 46 conditions